SG Americas Securities’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-47,124
| Closed | -$107K | – | 3645 |
|
|
2024
Q2 | $107K | Buy |
47,124
+33,588
| +248% | +$128K | ﹤0.01% | 2516 |
|
|
2024
Q1 | $58K | Buy |
+13,536
| New | +$47.2K | ﹤0.01% | 2721 |
|
|
2023
Q4 | – | Sell |
-37,726
| Closed | -$54K | – | 3514 |
|
|
2023
Q3 | $54K | Buy |
37,726
+173
| +0.5% | +$335 | ﹤0.01% | 2923 |
|
|
2023
Q2 | $94K | Sell |
37,553
-1,661
| -4% | -$4.54K | ﹤0.01% | 2093 |
|
|
2023
Q1 | $105K | Sell |
39,214
-7,833
| -17% | -$37.6K | ﹤0.01% | 2878 |
|
|
2022
Q4 | $255K | Buy |
47,047
+8,684
| +23% | +$72.8K | ﹤0.01% | 2043 |
|
|
2022
Q3 | $479K | Buy |
38,363
+207
| +0.5% | +$2.37K | 0.01% | 1588 |
|
|
2022
Q2 | $188K | Buy |
38,156
+142
| +0.4% | +$786 | ﹤0.01% | 2710 |
|
|
2022
Q1 | $289K | Sell |
38,014
-8,655
| -19% | -$82.1K | ﹤0.01% | 2219 |
|
|
2021
Q4 | $476K | Sell |
46,669
-12,907
| -22% | -$164K | ﹤0.01% | 2199 |
|
|
2021
Q3 | $800K | Buy |
59,576
+19,229
| +48% | +$313K | ﹤0.01% | 2098 |
|
|
2021
Q2 | $885K | Sell |
40,347
-4,947
| -11% | -$110K | ﹤0.01% | 1639 |
|
|
2021
Q1 | $1.09M | Buy |
45,294
+15,354
| +51% | +$357K | 0.01% | 1474 |
|
|
2020
Q4 | $539K | Sell |
29,940
-30,323
| -50% | -$453K | ﹤0.01% | 1932 |
|
|
2020
Q3 | $696K | Buy |
60,263
+43,076
| +251% | +$711K | ﹤0.01% | 1418 |
|
|
2020
Q2 | $417K | Sell |
17,187
-4,506
| -21% | -$74.5K | ﹤0.01% | 2249 |
|
|
2020
Q1 | $239K | Buy |
+21,693
| New | +$405K | ﹤0.01% | 2385 |
|
|
2019
Q3 | – | Sell |
-4,884
| Closed | -$150K | – | 3266 |
|
|
2019
Q2 | $150K | Sell |
4,884
-14,688
| -75% | -$309K | ﹤0.01% | 2580 |
|
|
2019
Q1 | $325K | Sell |
19,572
-31,063
| -61% | -$589K | ﹤0.01% | 2202 |
|
|
2018
Q4 | $970K | Buy |
+50,635
| New | +$1.9M | 0.01% | 1355 |
|
|
2018
Q3 | – | Sell |
-9,758
| Closed | -$424K | – | 3513 |
|
|
2018
Q2 | $424K | Buy |
+9,758
| New | +$418K | ﹤0.01% | 2127 |
|
SG Americas Securities's GTHX Position: Q3 2024 in Review
SG Americas Securities sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q3 2024, closing a stake of 47,124 shares — an estimated $107K sold.
SG Americas Securities first reported a position in GTHX in Q2 2018 and held it in 21 quarters. The position peaked at $1.09M in Q1 2021. 0 funds tracked by Wall St. Rank hold GTHX as of Q3 2024.
- SG Americas Securities reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
- SG Americas Securities sold 47,124 G1 Therapeutics, Inc. Common Stock shares in Q3 2024, an estimated $107K.
- SG Americas Securities first reported a position in G1 Therapeutics, Inc. Common Stock in Q2 2018 and held it in 21 quarters.
- SG Americas Securities's G1 Therapeutics, Inc. Common Stock position peaked at $1.09M in Q1 2021.
- 0 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q3 2024.
Based on SG Americas Securities's 13F filing for Q3 2024, filed 3 Oct 2024.